Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
Lynch, R. W., Lowe, D., Protheroe, A., Driscoll, R., Rhodes, J. M., Arnott, I. D. R.
Published in Alimentary pharmacology & therapeutics (01.10.2013)
Published in Alimentary pharmacology & therapeutics (01.10.2013)
Get full text
Journal Article
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
HO, G. T, LEE, H. M, ARNOTT, I. D, SATSANGI, J, BRYDON, G, TING, T, HARE, N, DRUMMOND, H, SHAND, A. G, BARTOLO, D. C, WILSON, R. G, DUNLOP, M. G
Published in The American journal of gastroenterology (01.03.2009)
Published in The American journal of gastroenterology (01.03.2009)
Get full text
Journal Article
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis
Kennedy, N. A., Rhatigan, E., Arnott, I. D. R., Noble, C. L., Shand, A. G., Satsangi, J., Lees, C. W.
Published in Alimentary pharmacology & therapeutics (01.11.2013)
Published in Alimentary pharmacology & therapeutics (01.11.2013)
Get full text
Journal Article
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
Noble, C L, Abbas, A R, Cornelius, J, Lees, C W, Ho, G-T, Toy, K, Modrusan, Z, Pal, N, Zhong, F, Chalasani, S, Clark, H, Arnott, I D, Penman, I D, Satsangi, J, Diehl, L
Published in Gut (01.10.2008)
Published in Gut (01.10.2008)
Get full text
Journal Article
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
Kennedy, N. A., Kalla, R., Warner, B., Gambles, C. J., Musy, R., Reynolds, S., Dattani, R., Nayee, H., Felwick, R., Harris, R., Marriott, S., Senanayake, S. M., Lamb, C. A., Al‐Hilou, H., Gaya, D. R., Irving, P. M., Mansfield, J., Parkes, M., Ahmad, T., Cummings, J. R. F., Arnott, I. D., Satsangi, J., Lobo, A. J., Smith, M., Lindsay, J. O., Lees, C. W.
Published in Alimentary pharmacology & therapeutics (01.12.2014)
Published in Alimentary pharmacology & therapeutics (01.12.2014)
Get full text
Journal Article
The safety profile of anti‐tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient‐years follow‐up
LEES, C. W., ALI, A. I., THOMPSON, A. I., HO, G.‐T., FORSYTHE, R. O., MARQUEZ, L., COCHRANE, C. J., AITKEN, S., FENNELL, J., ROGERS, P., SHAND, A. G., PENMAN, I. D., PALMER, K. R., WILSON, D. C., ARNOTT, I. D. R., SATSANGI, J.
Published in Alimentary pharmacology & therapeutics (01.02.2009)
Published in Alimentary pharmacology & therapeutics (01.02.2009)
Get full text
Journal Article
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
LEES, C. W., HEYS, D., HO, G. T., NOBLE, C. L., SHAND, A. G., MOWAT, C., BOULTON‐JONES, R., WILLIAMS, A., CHURCH, N., SATSANGI, J., ARNOTT, I. D. R.
Published in Alimentary Pharmacology and Therapeutics (01.08.2007)
Published in Alimentary Pharmacology and Therapeutics (01.08.2007)
Get full text
Journal Article
The use of adalimumab in the management of refractory Crohn’s disease
HO, G.‐T., SMITH, L., AITKEN, S., LEE, H. M., TING, T., FENNELL, J., LEES, C. W., PALMER, K. R., PENMAN, I. D., SHAND, A. G., ARNOTT, I. D., SATSANGI, J.
Published in Alimentary pharmacology & therapeutics (15.02.2008)
Published in Alimentary pharmacology & therapeutics (15.02.2008)
Get full text
Journal Article
Efficacy and complications of adalimumab treatment for medically‐refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004–2008)
HO, G. T., MOWAT, A., POTTS, L., CAHILL, A., MOWAT, C., LEES, C. W., HARE, N. C., WILSON, J. A., BOULTON‐JONES, R., PRIEST, M., WATTS, D. A., SHAND, A. G., ARNOTT, I. D., RUSSELL, R. K., WILSON, D. C., MORRIS, A. J., SATSANGI, J.
Published in Alimentary pharmacology & therapeutics (01.03.2009)
Published in Alimentary pharmacology & therapeutics (01.03.2009)
Get full text
Journal Article
Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations
WALKER, L. J., ALDHOUS, M. C., DRUMMOND, H. E., SMITH, B. R. K., NIMMO, E. R., ARNOTT, I. D. R., SATSANGI, J.
Published in Clinical and experimental immunology (01.03.2004)
Published in Clinical and experimental immunology (01.03.2004)
Get full text
Journal Article
NOD2 CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
Arnott, I D R, Nimmo, E R, Drummond, H E, Fennell, J, Smith, B R K, MacKinlay, E, Morecroft, J, Anderson, N, Kelleher, D, O'Sullivan, M, McManus, R, Satsangi, J
Published in Genes and immunity (01.07.2004)
Published in Genes and immunity (01.07.2004)
Get full text
Journal Article
Anti‐Saccharomyces cerevisiae Antibodies Status Is Associated with Oral Involvement and Disease Severity in Crohn Disease
Russell, RK, Ip, B, Aldhous, MC, MacDougall, M, Drummond, HE, Arnott, IDR, Gillett, PM, McGrogan, P, Weaver, LT, Bisset, WM, Mahdi, G, Wilson, DC, Satsangi, J
Published in Journal of pediatric gastroenterology and nutrition (01.02.2009)
Published in Journal of pediatric gastroenterology and nutrition (01.02.2009)
Get full text
Journal Article
Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe
Van Limbergen, J., Russell, R.K., Nimmo, E.R., Törkvist, L., Lees, C.W., Drummond, H.E., Smith, L., Anderson, N.H., Gillett, P.M., McGrogan, P., Hassan, K., Weaver, L.T., Bisset, W.M., Mahdi, G., Arnott, I.D., Sjöqvist, U., Lördal, M., Farrington, S.M., Dunlop, M.G., Wilson, D.C., Satsangi, J.
Published in Inflammatory bowel diseases (01.07.2007)
Published in Inflammatory bowel diseases (01.07.2007)
Get full text
Journal Article